Position in GH
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,525,655
+$608,883 QoQ
Shares Held
10,169
+2.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#281
of 593 holders
Holding Since
Jun 2023
4 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $750,824,495 across 25 Diagnostics & Research names. GH ranks #19 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
16,187,054 | $382,526,542 | |
| 2 | DHR |
Danaher Corp /De/
|
705,975 | $134,474,118 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
115,405 | $60,753,808 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
26,295 | $33,592,125 | |
| 5 | A |
Agilent Technologies, Inc.
|
243,555 | $32,351,410 | |
| 6 | ICLR |
Icon PLC
|
114,844 | $19,949,551 | |
| 7 | RVTY |
Revvity, Inc.
|
162,985 | $18,133,711 | |
| 8 | ILMN |
Illumina, Inc.
|
91,197 | $16,035,168 |
All Filings in GH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,525,655 | 10,169 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $916,772 | 9,925 | Shares | Sole | 2026-05-15 | |
| 2023-09-30 | $462,769 | 15,613 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $613,647 | 17,141 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||